1. Home
  2. QNRX vs BKYI Comparison

QNRX vs BKYI Comparison

Compare QNRX & BKYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNRX
  • BKYI
  • Stock Information
  • Founded
  • QNRX 2018
  • BKYI 1993
  • Country
  • QNRX United States
  • BKYI United States
  • Employees
  • QNRX N/A
  • BKYI N/A
  • Industry
  • QNRX Medical/Dental Instruments
  • BKYI Computer Software: Prepackaged Software
  • Sector
  • QNRX Health Care
  • BKYI Technology
  • Exchange
  • QNRX Nasdaq
  • BKYI Nasdaq
  • Market Cap
  • QNRX 5.3M
  • BKYI 3.2M
  • IPO Year
  • QNRX N/A
  • BKYI 1997
  • Fundamental
  • Price
  • QNRX $0.70
  • BKYI $1.67
  • Analyst Decision
  • QNRX Strong Buy
  • BKYI
  • Analyst Count
  • QNRX 1
  • BKYI 0
  • Target Price
  • QNRX $4.00
  • BKYI N/A
  • AVG Volume (30 Days)
  • QNRX 1.4M
  • BKYI 648.5K
  • Earning Date
  • QNRX 11-07-2024
  • BKYI 11-14-2024
  • Dividend Yield
  • QNRX N/A
  • BKYI N/A
  • EPS Growth
  • QNRX N/A
  • BKYI N/A
  • EPS
  • QNRX N/A
  • BKYI N/A
  • Revenue
  • QNRX N/A
  • BKYI $7,292,394.00
  • Revenue This Year
  • QNRX N/A
  • BKYI $1.96
  • Revenue Next Year
  • QNRX N/A
  • BKYI $9.65
  • P/E Ratio
  • QNRX N/A
  • BKYI N/A
  • Revenue Growth
  • QNRX N/A
  • BKYI N/A
  • 52 Week Low
  • QNRX $0.43
  • BKYI $0.52
  • 52 Week High
  • QNRX $6.18
  • BKYI $3.22
  • Technical
  • Relative Strength Index (RSI)
  • QNRX 54.60
  • BKYI 59.53
  • Support Level
  • QNRX $0.47
  • BKYI $1.29
  • Resistance Level
  • QNRX $0.75
  • BKYI $2.68
  • Average True Range (ATR)
  • QNRX 0.10
  • BKYI 0.29
  • MACD
  • QNRX 0.01
  • BKYI 0.08
  • Stochastic Oscillator
  • QNRX 71.51
  • BKYI 44.81

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

About BKYI BIO-key International Inc.

BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.

Share on Social Networks: